Clinical Trial Update: Circadian Rhythm In Tobramycin Elimination In Cystic Fibrosis [Phase 4]

View source ↗

Summary

The Phase 4 clinical trial from the University of Nottingham explored circadian rhythm effects on tobramycin elimination in cystic fibrosis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TOBRAMYCIN (Tobramycin)

Snippet

Sponsor: University of Nottingham | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED